$GCTK
GlucoTrack Inc Stock $gctk

$gctk Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-K Financial Statement

#000117891315001111 Filed on March 31, 2015

Income Statement

Concept	2015 Q1	2014 Q4	2014
Revenue	$80.00K	$30.00K	$59.78K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$480.0K	$520.0K	$1.818M
YoY Change	10.07%	108.0%	74.57%
% of Gross Profit
Research & Development	$480.0K	$520.0K	$1.850M
YoY Change	6.41%	-1.89%	-6.9%
% of Gross Profit
Depreciation & Amortization	$8.770K	$0.00	$34.68K
YoY Change	8.33%	-100.0%	2.97%
% of Gross Profit
Operating Expenses	$960.0K	$1.040M	$3.667M
YoY Change	8.21%	33.33%	21.11%
Operating Profit			-$3.607M
YoY Change			19.14%
Interest Expense	-$650.0K	$30.00K	$30.00K
YoY Change	-533.33%	-100.47%	-127.27%
% of Operating Profit
Other Income/Expense, Net		$210.0K	$6.560M
YoY Change			-198.5%
Pretax Income	-$1.530M	-$780.0K	$2.980M
YoY Change	106.76%	-89.14%	-130.42%
Income Tax
% Of Pretax Income
Net Earnings	-$1.535M	$5.110M	$2.980M
YoY Change	108.24%	-167.68%	-130.42%
Net Earnings / Revenue	-1918.16%	17033.33%	4986.07%
Basic Earnings Per Share			$0.37
Diluted Earnings Per Share	-$4.00	$12.46	$0.37
COMMON SHARES
Basic Shares Outstanding	5.323M shares	5.307M shares	5.305M shares
Diluted Shares Outstanding			5.349M shares

Balance Sheet

Concept	2015 Q1	2014 Q4	2014
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.700M	$5.830M	$5.830M
YoY Change	190.12%	143.93%	143.93%
Cash & Equivalents	$4.695M	$5.828M	$5.830M
Short-Term Investments
Other Short-Term Assets	$111.6K	$113.8K	$120.0K
YoY Change	26.09%	22.34%	33.33%
Inventory	$75.21K	$83.65K	$80.00K
Prepaid Expenses		$46.09K
Receivables	$4.069K	$23.25K	$20.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.886M	$6.048M	$6.050M
YoY Change	186.47%	143.99%	143.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$123.0K	$122.5K	$120.0K
YoY Change	14.45%	14.25%	9.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$170.0K	$180.0K	$180.0K
YoY Change	0.0%	5.88%	5.88%
Total Long-Term Assets	$296.4K	$300.0K	$300.0K
YoY Change	7.12%	8.19%	7.14%
TOTAL ASSETS
Total Short-Term Assets	$4.886M	$6.048M	$6.050M
Total Long-Term Assets	$296.4K	$300.0K	$300.0K
Total Assets	$5.183M	$6.348M	$6.350M
YoY Change	161.44%	130.33%	130.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$221.6K	$104.7K	$100.0K
YoY Change	63.45%	110.32%	100.0%
Accrued Expenses		$235.9K	$440.0K
YoY Change		434.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$0.00	$450.0K	$450.0K
YoY Change
Total Short-Term Liabilities	$728.5K	$1.000M	$1.000M
YoY Change	44.0%	221.64%	222.58%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.340M	$2.430M	$2.430M
YoY Change	-85.09%	-73.44%	-73.44%
Total Long-Term Liabilities	$1.339M	$2.432M	$2.430M
YoY Change	-85.1%	-73.41%	-73.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$728.5K	$1.000M	$1.000M
Total Long-Term Liabilities	$1.339M	$2.432M	$2.430M
Total Liabilities	$2.068M	$3.432M	$3.430M
YoY Change	-78.23%	-63.71%	-63.74%
SHAREHOLDERS EQUITY
Retained Earnings	-$24.73M	-$23.09M
YoY Change	-6.64%	-10.0%
Common Stock	$20.43M	$18.19M
YoY Change	40.31%	25.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.274M	-$4.832M	$2.920M
YoY Change
Total Liabilities & Shareholders Equity	$5.183M	$6.348M	$6.350M
YoY Change	161.44%	130.33%	130.07%

Cashflow Statement

Concept	2015 Q1	2014 Q4	2014
OPERATING ACTIVITIES
Net Income	-$1.535M	$5.110M	$2.980M
YoY Change	108.24%	-167.68%	-130.42%
Depreciation, Depletion And Amortization	$8.770K	$0.00	$34.68K
YoY Change	8.33%	-100.0%	2.97%
Cash From Operating Activities	-$600.0K	-$940.0K	-$3.360M
YoY Change	-13.04%	0.0%	4.35%
INVESTING ACTIVITIES
Capital Expenditures	$12.11K	$10.00K	$63.46K
YoY Change	36.72%	0.0%	-1.24%
Acquisitions
YoY Change
Other Investing Activities		$0.00	-$30.00K
YoY Change			-25.0%
Cash From Investing Activities	-$10.00K	-$10.00K	-$90.00K
YoY Change	0.0%	0.0%	-10.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-460.0K	2.430M	6.970M
YoY Change	557.14%	-1450.0%	37.75%
NET CHANGE
Cash From Operating Activities	-600.0K	-940.0K	-3.360M
Cash From Investing Activities	-10.00K	-10.00K	-90.00K
Cash From Financing Activities	-460.0K	2.430M	6.970M
Net Change In Cash	-1.070M	1.480M	3.520M
YoY Change	38.96%	-230.97%	102.3%
FREE CASH FLOW
Cash From Operating Activities	-$600.0K	-$940.0K	-$3.360M
Capital Expenditures	$12.11K	$10.00K	$63.46K
Free Cash Flow	-$612.1K	-$950.0K	-$3.423M
YoY Change	-12.41%	0.0%	4.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	83653	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet		USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	113842	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	93052	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	6048305	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2478963	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	122491	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107209	USD
CY2014Q4	igap	Funds In Respect Of Employee Rights Upon Retirement Noncurrent FundsInRespectOfEmployeeRightsUponRetirementNoncurrent	177470	USD
CY2013Q4	igap	Funds In Respect Of Employee Rights Upon Retirement Noncurrent FundsInRespectOfEmployeeRightsUponRetirementNoncurrent	170033	USD
CY2014Q4	us-gaap	Assets Assets	6348266	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	104711	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	49787	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	440764	USD
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	261120	USD
CY2014Q4	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	454532	USD
CY2013Q4	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent		USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1000007	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	310907	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	6972950	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1849624	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013	us-gaap	Revenues Revenues		USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5827560	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2385911	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23250	USD
CY2013Q4	us-gaap	Assets Assets	2756205	USD
CY2014Q4	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	163459	USD
CY2014Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	7748685	USD
CY2013Q4	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	693092	USD
CY2014Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	210700	USD
CY2013Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	236074	USD
CY2014Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2057618	USD
CY2013Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	8216705	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2431777	USD
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9145871	USD
CY2014Q4	us-gaap	Liabilities Liabilities	3431784	USD
CY2013Q4	us-gaap	Liabilities Liabilities	9456778	USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5323059	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5301693	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	5324	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2756205	USD
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2014	us-gaap	Revenues Revenues	59775	USD
CY2013Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	4362545	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	18182866	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	66670	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23087063	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-4832203	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	852908	USD
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	3667134	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	3027894	USD
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	2773598	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-3607359	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-11063118	USD
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5301693	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5323059	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-3027894	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-2773598	USD
CY2014	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	-6587785	USD
CY2013	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	6768959	USD
CY2012	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	-1291	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	2980426	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-2772307	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-13968	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6348266	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	5302	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14532068	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	52702	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25653190	USD
CY2012	us-gaap	Revenues Revenues		USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1986754	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1920690	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1817510	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1041140	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-43777	USD
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	13709	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2966458	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9840630	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2758598	USD
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.95
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.95
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5304500	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5325714	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5314800	shares
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	968239	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-13709	USD
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	917179	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	48007	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	349522	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-503069	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-9796853	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	43777	USD
CY2013	us-gaap	Stockholders Equity Other StockholdersEquityOther	1140349	USD
CY2013	igap	Stock Issued During Period Value Conversion Of Convertible Preferred Stock StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock	23200	USD
CY2013	us-gaap	Dividends Stock DividendsStock		USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	562805	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	35619	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	13968	USD
CY2014	igap	Adjustments To Additional Paid In Capital Investor Warrant Issued AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued	3320429	USD
CY2014	igap	Stock Issued During Period Value Conversion Of Convertible Preferred Stock StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock	5888	USD
CY2014	us-gaap	Dividends Stock DividendsStock		USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	630936	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	50380	USD
CY2014	igap	Adjustments To Additional Paid In Capital Reclassification Out Of Stockholders Equity To Liabilities AdjustmentsToAdditionalPaidInCapitalReclassificationOutOfStockholdersEquityToLiabilities	400671	USD
CY2014	us-gaap	Depreciation Depreciation	34683	USD
CY2013	us-gaap	Depreciation Depreciation	33684	USD
CY2012	us-gaap	Depreciation Depreciation	25546	USD
CY2014	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations		USD
CY2013	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	-9959	USD
CY2012	us-gaap	Increase Decrease In Postemployment Obligations IncreaseDecreaseInPostemploymentObligations	-17237	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	50380	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	35619	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	349522	USD
CY2013	us-gaap	Other Noncash Expense OtherNoncashExpense	390928	USD
CY2012	us-gaap	Other Noncash Expense OtherNoncashExpense		USD
CY2014	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6559758	USD
CY2013	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	6251242	USD
CY2012	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-35892	USD
CY2014	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	-556	USD
CY2013	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	14382	USD
CY2012	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	9849	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	24539	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	94895	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		USD
CY2014	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	32416	USD
CY2013	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5234	USD
CY2012	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-14106	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	68838	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-77259	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	48850	USD
CY2014	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	216192	USD
CY2013	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-54317	USD
CY2012	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	80574	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3361645	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3217767	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2296989	USD
CY2014	igap	Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement	-28058	USD
CY2013	igap	Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement	-40029	USD
CY2012	igap	Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement	-6387	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	63455	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64252	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11347	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-91513	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-104281	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-17734	USD
CY2014	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt		USD
CY2013	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-38801	USD
CY2012	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	36348	USD
CY2014	igap	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts		USD
CY2013	igap	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts		USD
CY2012	igap	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts	917179	USD
CY2014	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	370441	USD
CY2013	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	288248	USD
CY2012	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock		USD
CY2014	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	3710860	USD
CY2013	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	3960958	USD
CY2012	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		USD
CY2013	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1421983	USD
CY2012	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		USD
CY2014	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3632531	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1842500	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5055892	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	953527	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-78143	USD
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	108656	USD
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	8103	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3441649	USD
CY2012	us-gaap	Revenue From Grants RevenueFromGrants	0	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1353093	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	543411	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1896504	USD
CY2014	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	630936	USD
CY2013	us-gaap	Proceeds From Repurchase Of Redeemable Preferred Stock ProceedsFromRepurchaseOfRedeemablePreferredStock	5300000	USD
	us-gaap	Proceeds From Repurchase Of Redeemable Preferred Stock ProceedsFromRepurchaseOfRedeemablePreferredStock	7300000	USD
CY2004	us-gaap	Revenue From Grants RevenueFromGrants	93300	USD
CY2014	us-gaap	Revenue From Grants RevenueFromGrants	1793	USD
CY2013	us-gaap	Revenue From Grants RevenueFromGrants	0	USD
CY2014	igap	Average Foreign Currency Exchange Rate Translation AverageForeignCurrencyExchangeRateTranslation	0.257	pure
CY2013	igap	Average Foreign Currency Exchange Rate Translation AverageForeignCurrencyExchangeRateTranslation	0.288	pure
CY2012	igap	Average Foreign Currency Exchange Rate Translation AverageForeignCurrencyExchangeRateTranslation	0.268	pure
CY2014	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	101220	USD
CY2013	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	91588	USD
CY2012	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	78556	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	16459	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11637	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods		USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	29044	USD
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font-size: 10pt; line-height: 150%; margin: 0pt 0pt 0pt 90.75pt; text-align: justify; text-indent: -22.7pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>A.</strong><strong>     </strong><strong>Use of estimates in the preparation of financial statements</strong></font></p> <p style="margin: 0pt 0pt 0pt 90.8pt; text-align: justify; text-indent: -22.7pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"> </font></p> <p style="margin: 0pt 0pt 0pt 90pt; text-align: justify; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to (a) the allocation of proceeds and related issuance costs of the Series A Units, (b) the allocation of the proceeds and the related issuance costs of the Series B Units, (c) the fair value estimate of the Series A Warrants (which include down-round protection) and (d) the going concern assumptions.</font></p> </div>
CY2014Q4	us-gaap	Prepaid Taxes PrepaidTaxes	67748	USD
CY2013Q4	us-gaap	Prepaid Taxes PrepaidTaxes	64008	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	44093	USD
CY2014	us-gaap	Revenue Recognition Services Royalty Fees RevenueRecognitionServicesRoyaltyFees	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font-size: 10pt; line-height: 150%; margin: 0pt 0pt 0pt 90.8pt; text-align: justify; text-indent: -22.7pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>L</strong><strong>.</strong><strong>     </strong><strong>Royalty-bearing grants</strong></font></p> <p style="margin: 0pt 0pt 0pt 90.8pt; text-align: justify; text-indent: -22.7pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"> </font></p> <p style="margin: 0pt 0pt 6pt 90.8pt; text-align: justify; font-family: 'times new roman'; margin-bottom: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">Royalty-bearing grants from the OCS to fund approved research and development projects are recognized at the time Integrity Israel is entitled to such grants, on the basis of the costs incurred and reduce research and development costs. The cumulative research and development grants received by Integrity Israel from inception through December 2004 amounted to $<font>93,300</font>. Integrity Israel has not received any research and development grants since December 2004.</font></p> <p style="margin: 0pt 0pt 0pt 90.8pt; text-align: justify; text-indent: -22.7pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"> </font></p> <p style="margin: 0pt 0pt 0pt 90.8pt; text-align: justify; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">As of December 31, 2014, 2013 and 2012, the Group accrued royalties to the OCS in the amounts of $<font>1,793</font>, $<font>0</font> and $<font>0</font>, respectively.</font></p> </div>
CY2013Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess		USD
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	46094	USD
CY2014	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font-size: 10pt; line-height: 150%; margin: 0pt 0pt 0pt 90.8pt; text-align: justify; text-indent: -22.7pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"><strong>Q</strong><strong>.</strong><strong>     </strong><strong>Concentrations of credit risk</strong></font></p> <p style="margin: 0pt 0pt 0pt 90.8pt; text-align: justify; text-indent: -22.7pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;"> </font></p> <p style="margin: 0pt 0pt 0pt 90.7pt; text-align: justify; font-family: 'times new roman';"><font style="color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; float: none; display: inline !important; /* background-color: #ffffff;">Financial instruments that potentially subject the Group to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.  Cash and cash equivalents are deposited with major banks in Israel and the United States of America. Management believes that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Group does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</font></p> </div>
CY2014	igap	Standard Product Warranty Term StandardProductWarrantyTerm	P24M
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	55557	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials		USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	331532	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	305648	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	209041	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	198439	USD
CY2014Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	104711	USD
CY2014	igap	Registration Payment Arrangement Period During Which Placement Agent Have Right Of First Refusal RegistrationPaymentArrangementPeriodDuringWhichPlacementAgentHaveRightOfFirstRefusal	P24M
CY2013Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	8085	USD
CY2013Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	41702	USD
CY2014Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent		USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	204890	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	217027	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	235874	USD
CY2014Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	77141	USD
CY2014Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	300000	ILS
CY2014	igap	Percent Of Future Sales Designated To Repay Stockholders Loans PercentOfFutureSalesDesignatedToRepayStockholdersLoans	0.10	pure
CY2014Q4	igap	Area Of Leased Space AreaOfLeasedSpace	3100
CY2014Q4	igap	Monthly Lease Commitment MonthlyLeaseCommitment	2957	USD
CY2014Q4	igap	Monthly Lease Commitment MonthlyLeaseCommitment	11500	ILS
CY2014Q4	igap	Stock Price At Which Stock Dividend Is Declared StockPriceAtWhichStockDividendIsDeclared	5.80
CY2005Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2007Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	450847	shares
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	302360	shares
CY2014Q4	igap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Expected To Be Recognized In Year One EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostExpectedToBeRecognizedInYearOne	37000	USD
CY2014Q4	igap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Expected To Be Recognized In Year Two EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostExpectedToBeRecognizedInYearTwo	3000	USD
CY2014	us-gaap	Labor And Related Expense LaborAndRelatedExpense	651900	USD
CY2013	us-gaap	Labor And Related Expense LaborAndRelatedExpense	260276	USD
CY2012	us-gaap	Labor And Related Expense LaborAndRelatedExpense	255839	USD
CY2014	us-gaap	Professional Fees ProfessionalFees	739893	USD
CY2013	us-gaap	Professional Fees ProfessionalFees	562435	USD
CY2012	us-gaap	Professional Fees ProfessionalFees	392832	USD
CY2014	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	200348	USD
CY2013	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	128095	USD
CY2012	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	119757	USD
CY2014	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	40087	USD
CY2013	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	26529	USD
CY2012	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	14506	USD
CY2014	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	185282	USD
CY2013	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	63805	USD
CY2012	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	69974	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	25282	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-94815	USD
CY2012	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-18147	USD
CY2014	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	6559758	USD
CY2013	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-6251242	USD
CY2012	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	35892	USD
CY2014	us-gaap	Recapitalization Costs RecapitalizationCosts		USD
CY2013	us-gaap	Recapitalization Costs RecapitalizationCosts	390928	USD
CY2012	us-gaap	Recapitalization Costs RecapitalizationCosts		USD
CY2014	us-gaap	Interest Expense Debt InterestExpenseDebt	-2189	USD
CY2013	us-gaap	Interest Expense Debt InterestExpenseDebt	17592	USD
CY2012	us-gaap	Interest Expense Debt InterestExpenseDebt	6605	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2980426	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9796853	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2772307	USD
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1043149	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3428899	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-970307	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	27250	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	21250	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	4553	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	14415	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	10570	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	122333	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-2295915	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	2324760	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther		USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	278466	USD
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	253942	USD
CY2012	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	277231	USD
CY2014	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	932635	USD
CY2013	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	818377	USD
CY2012	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	566190	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	20220	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	33629	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	47440	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4810780	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4364466	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3496123	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4831000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4398095	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3543563	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2014	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments		USD
CY2013	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	278263	USD
CY2012	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments		USD
CY2014	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	596472	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1969655	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10363363	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2772307	USD
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5349242	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5325714	shares
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5314800	shares
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4557612	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2813493	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600232	shares
CY2014	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	item
CY2014Q4	igap	Foreign Currency Exchange Rate ForeignCurrencyExchangeRate	3.889	pure
CY2014	dei	Entity Registrant Name EntityRegistrantName	Integrity Applications, Inc.
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0001506983
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-12-31
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014Q2	dei	Entity Public Float EntityPublicFloat	42798070	USD
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5323059	shares
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY

Files In Submission

Name	View Source	Status
0001178913-15-001111-index-headers.html	Edgar Link	pending
0001178913-15-001111-index.html	Edgar Link	pending
0001178913-15-001111.txt	Edgar Link	pending
0001178913-15-001111-xbrl.zip	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
grant_thorntonpahnkanne.jpg	Edgar Link	pending
igap-20141231.xml	Edgar Link	completed
igap-20141231.xsd	Edgar Link	pending
igap-20141231_cal.xml	Edgar Link	unprocessable
igap-20141231_def.xml	Edgar Link	unprocessable
igap-20141231_lab.xml	Edgar Link	unprocessable
igap-20141231_pre.xml	Edgar Link	unprocessable
img01.jpg	Edgar Link	pending
img02.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk1516513.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GCTK
GlucoTrack Inc Stock $gctk

2015 Q1 Form 10-K Financial Statement

#000117891315001111 Filed on March 31, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GCTK GlucoTrack Inc Stock $gctk

2015 Q1 Form 10-K Financial Statement

#000117891315001111 Filed on March 31, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GCTK
GlucoTrack Inc Stock $gctk